These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1801 related articles for article (PubMed ID: 33569200)

  • 1. Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials.
    Ebina-Shibuya R; Namkoong H; Horita N; Kato H; Hara Y; Kobayashi N; Kaneko T
    J Thorac Dis; 2021 Jan; 13(1):202-212. PubMed ID: 33569200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
    Eze P; Mezue KN; Nduka CU; Obianyo I; Egbuche O
    Am J Cardiovasc Dis; 2021; 11(1):93-107. PubMed ID: 33815925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions.
    Souza Botelho M; Bolfi F; Leite RGOF; Leite MSF; Banzato LR; Soares LT; Olivatti TOF; Mangolim AS; Oliveira FRK; Abbade LPF; Abbade JF; de Barros Almeida RAM; Simões Corrêa Galendi J; Thabane L; Dos Santos Nunes-Nogueira V
    Syst Rev; 2021 Nov; 10(1):294. PubMed ID: 34736537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19.
    Mittal N; Mittal R; Gupta MC; Kaushal J; Chugh A; Khera D; Singh S
    J Family Med Prim Care; 2021 Jun; 10(6):2126-2139. PubMed ID: 34322403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy.
    Celotto S; Veronese N; Barbagallo M; Ometto F; Smith L; Pardhan S; Barnett Y; Ilie PC; Soysal P; Lagolio E; Kurotschka PK; Tonelli R; Demurtas J
    Int J Infect Dis; 2021 Feb; 103():599-606. PubMed ID: 33316389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
    Ren L; Xu W; Overton JL; Yu S; Chiamvimonvat N; Thai PN
    Front Pharmacol; 2020; 11():562777. PubMed ID: 33154723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis.
    Kashour Z; Riaz M; Garbati MA; AlDosary O; Tlayjeh H; Gerberi D; Murad MH; Sohail MR; Kashour T; Tleyjeh IM
    J Antimicrob Chemother; 2021 Jan; 76(1):30-42. PubMed ID: 33031488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
    Elavarasi A; Prasad M; Seth T; Sahoo RK; Madan K; Nischal N; Soneja M; Sharma A; Maulik SK; Shalimar ; Garg P
    J Gen Intern Med; 2020 Nov; 35(11):3308-3314. PubMed ID: 32885373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
    Di Stefano L; Ogburn EL; Ram M; Scharfstein DO; Li T; Khanal P; Baksh SN; McBee N; Gruber J; Gildea MR; Clark MR; Goldenberg NA; Bennani Y; Brown SM; Buckel WR; Clement ME; Mulligan MJ; O'Halloran JA; Rauseo AM; Self WH; Semler MW; Seto T; Stout JE; Ulrich RJ; Victory J; Bierer BE; Hanley DF; Freilich D;
    PLoS One; 2022; 17(9):e0273526. PubMed ID: 36173983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Hydroxychloroquine and Chloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
    Ren L; Xu W; Overton JL; Yu S; Chiamvimonvat N; Thai PN
    medRxiv; 2020 May; ():. PubMed ID: 32511539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.
    Liu D; Li X; Zhang Y; Kwong JS; Li L; Zhang Y; Xu C; Li Q; Sun X; Tian H; Li S
    Drug Des Devel Ther; 2018; 12():1685-1695. PubMed ID: 29928112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19.
    Ho TC; Wang YH; Chen YL; Tsai WC; Lee CH; Chuang KP; Chen YA; Yuan CH; Ho SY; Yang MH; Tyan YC
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33671315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.
    Chivese T; Musa OAH; Hindy G; Al-Wattary N; Badran S; Soliman N; Aboughalia ATM; Matizanadzo JT; Emara MM; Thalib L; Doi SAR
    Travel Med Infect Dis; 2021; 43():102135. PubMed ID: 34265436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
    Di Stefano L; Ogburn EL; Ram M; Scharfstein DO; Li T; Khanal P; Baksh SN; McBee N; Gruber J; Gildea MR; Clark MR; Goldenberg NA; Bennani Y; Brown SM; Buckel WR; Clement ME; Mulligan MJ; O'Halloran JA; Rauseo AM; Self WH; Semler MW; Seto T; Stout JE; Ulrich RJ; Victory J; Bierer BE; Hanley DF; Freilich D
    medRxiv; 2022 Aug; ():. PubMed ID: 35043124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS).
    Zhao Y; Zhang J; Zheng K; Thai S; Simpson RJ; Kinlaw AC; Xu Y; Wei J; Cui X; Buse JB; Stürmer T; Wang T
    Drugs Real World Outcomes; 2022 Jun; 9(2):231-241. PubMed ID: 35386046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis.
    Das RR; Jaiswal N; Dev N; Jaiswal N; Naik SS; Sankar J
    Front Med (Lausanne); 2020; 7():482. PubMed ID: 32850924
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 Infection in Rheumatic Patients on Chronic Antimalarial Drugs: A Systematic Review and Meta-Analysis.
    Landsteiner de Sampaio Amêndola I; Aires Pinheiro J; Póvoa P; Cés de Souza Dantas V; Serafim RB
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety.
    Takla M; Jeevaratnam K
    Saudi Pharm J; 2020 Dec; 28(12):1760-1776. PubMed ID: 33204210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis and clinical assessment: an updated meta-analysis of randomized trials.
    Han X; Shi W; Yang Y
    J Thorac Dis; 2024 May; 16(5):2983-2993. PubMed ID: 38883686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Hydroxychloroquine in COVID-19: A Systematic Review and Meta-Analysis.
    Ullah W; M Abdullah H; Roomi S; Sattar Y; Almas T; Narayana Gowda S; Saeed R; Mukhtar M; Ahmad A; Oliver T; Alraies MC; Haas DC; Fischman DL
    J Clin Med Res; 2020 Aug; 12(8):483-491. PubMed ID: 32849936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.